News

Currently, Galena markets Abstral (fentanyl) sublingual tablets for the treatment of breakthrough cancer pain. A dedicated GPS team works with the healthcare professionals, patients, and insurance providers to

The new joint venture will be a private entity, initially with equal ownership by Ohr and Cold Spring Harbor Laboratory. The two partners will seek funding and contribute

The multicenter, randomized, double-masked, dose-ranging Safety and Efficacy Assessment Treatment Trials of Emixustat hydrochloride (SEATTLE) trial is started in early 2013. A total of 508 patients with GA

Severe aplastic anaemia is a rare disorder in which the bone marrow fails to make enough new blood cells. Currently, there are no approved therapies available for SAA

Recruitment is currently in process for the multicenter trial, which is being conducted in partnership with the Academic and Community Cancer Research United (ACCRU) group. Across the US,

The company’s development product candidate NeuVax is the immunodominant nonapeptide derived from the extracellular domain of the HER2 protein, a well-established target for therapeutic intervention in breast carcinoma.

The building, which will be built with an investment of about JPY2.22bn ($21.9m), is expected to be completed in March 2015. The construction project is part of the

IPF causes scarring of the lungs, irreversibly destroying normal lung architecture and hindering a person’s ability to breathe. The disease typically occurs in patients over the age of

MEI Pharma is a US-based oncology firm focused on the clinical development of novel therapies for cancer. Pracinostat is an orally available histone deacetylase (HDAC) inhibitor that has